EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-34 aggravates myocardial ischemia-reperfusion injury by upregulating the HMGB1-IL-17A-IL-6 axis through the JAK signaling pathway

Ruisong Ma iD, Xiaochun Hu, Wenwen Fu, Xiaorong Hu

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0315489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Ruisong Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hainan General Hospital, Haikou, PR China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Interleukin-17, Signal Transduction, HMGB1 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hainan Province, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-34 (IL-34) was recently reported to be a new biomarker for atherosclerosis diseases, such as coronary artery disease and vascular dementia. IL-34 regulates the expression of proinflammatory cytokines (IL-17A, IL-1 and IL-6), which are classical cytokines involved in myocardial ischemia‒reperfusion (MI/R) injury. However, the exact role of IL-34 in MI/R remains unknown. In this study, a rat MI/R model was used to explore the effect of IL-34 on modulating inflammatory processes during MI/R injury. First, eighteen rats were subjected to 30 min of LAD ligation followed by 0 h, 1 h, 2 h, 4 h, 8 h or 24 h of reperfusion (n = 3 for each group). The level of IL-34 peaked at 4 h after MI/R in the ischemic myocardium. Next, ischemia for 30min and reperfusion for 4h (I/R) model was used. 24 rats were randomly divided into I/R group (n = 8), IL-34+IR group (n = 8) and IL-34+ab12+IR group (n = 8). We found that IL-34 pretreatment increased the expression of inflammatory cytokines, including high mobility group Box 1 (HMGB1), IL-17A, and IL-6; the expression of the apoptosis protein cleaved caspase-3; and the Bcl-2/Bax ratio within the ischemic myocardium. We also observed increased serum cardiac enzymes and a larger myocardial injury area. Treatment with a Janus kinase (JAK) pathway inhibitor, however, partially reduced the expression of these proteins and attenuated myocardial injury. Together, these results showed that IL-34 aggravates MI/R injury by inducing the expression of the HMGB1-IL-17A-IL-6 axis and apoptosis after MI/R, which is partially dependent on the JAK pathway. Therefore, blocking the JAK signaling pathway or inhibiting IL-34 expression might provide a new idea to reduce MI/R injury, but further researches are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryInterleukin-17Signal TransductionHMGB1 ProteinInterleukinsInterleukin-6Janus KinasesAnimalsMaleRatsRats, Sprague-DawleyUp-RegulationApoptosisMyocardium

Substanzen

Interleukin-17HMGB1 ProteinInterleukinsInterleukin-6Hbp1 protein, ratJanus KinasesIl17a protein, ratIl6 protein, rat

Autor:innen und Institutionen

  • Department of Cardiology, Hainan General Hospital, Haikou, PR China.
  • Hainan Affiliated Hospital of Hainan Medical University, Haikou, PR China.
  • Hainan Clinical Research Center for Cardiology, Haikou, PR China.
  • Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, PR China.
  • Cardiovascular Research Institute, Wuhan University, Wuhan, PR China.
  • Hubei Key Laboratory of Cardiology, Wuhan, PR China.

ORCID-Profile: Ruisong Ma

Förderung

  • Natural Science Foundation of Hainan Province
  • Natural Science Foundation of China

Zitieren

APA

Ma, R., Hu, X., Fu, W., & Hu, X. (2025). IL-34 aggravates myocardial ischemia-reperfusion injury by upregulating the HMGB1-IL-17A-IL-6 axis through the JAK signaling pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0315489

Vancouver

Ma R, Hu X, Fu W, Hu X. IL-34 aggravates myocardial ischemia-reperfusion injury by upregulating the HMGB1-IL-17A-IL-6 axis through the JAK signaling pathway. PLOS ONE. 2025. doi:10.1371/journal.pone.0315489

BibTeX
@article{Ma2025,
  author = {Ma, Ruisong and Hu, Xiaochun and Fu, Wenwen and Hu, Xiaorong},
  title = {IL-34 aggravates myocardial ischemia-reperfusion injury by upregulating the HMGB1-IL-17A-IL-6 axis through the JAK signaling pathway},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0315489}
}
Kostenlos starten →